ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619321 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619321; 2) Community: the network communities that were significantly associated with the response to NSC 619321; 3) Molecule: the relationships between components within communities and NSC 619321; 4) MDR: the compounds that were significantly associated with the NSC 619321.

NSC Compound Enrichment Correlation
NSC 95382 Camptothecin Derivative 0.0420893367628876 0.25985318
NSC 10660 Null 0.0420893367628879 0.031705314
NSC 123139 L-Cysteine, S-[(4-methylphenyl)diphenylmethyl]- (9CI) 0.0420893367628879 0.19573908
NSC 150094 1-Azabicyclo[2.2.2]octan-3-one, 2-(4-morpholinylmethyl)- 0.0420893367628879 -0.34933349
NSC 191909 .alpha.-Chloro-N-(p-methoxyphenyl)succinimide 0.0420893367628879 -0.28123439
NSC 328186 3',4',5'-trimethoxy-3-hydroxy flavone 0.0420893367628879 0.1951798
NSC 363979 Cephalostatin 1 0.0420893367628879 0.25018492
NSC 381866 BAFILOMYCIN DERIV. 0.0420893367628879 0.11075078
NSC 57199 3-[o-[Bis(.beta.-chloroethyl)amino]phenyl]-DL-alanine 0.0420893367628879 0.070948568
NSC 606698 Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt 0.0420893367628879 0.089570637
Total:44  Current:42    [First] [Prev] [Next] [Last]